SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,266,000 | -3.8% | 68,470 | +1.9% | 0.09% | 0.0% |
| Q1 2019 | $2,355,000 | -6.5% | 67,220 | -11.3% | 0.09% | -32.3% |
| Q4 2018 | $2,519,000 | -34.1% | 75,820 | -0.2% | 0.13% | -3.1% |
| Q3 2018 | $3,825,000 | -15.9% | 75,970 | 0.0% | 0.13% | -20.1% |
| Q2 2018 | $4,547,000 | +42.3% | 75,970 | +8.9% | 0.16% | +40.2% |
| Q1 2018 | $3,195,000 | +17.8% | 69,765 | +0.5% | 0.12% | +24.5% |
| Q4 2017 | $2,712,000 | -2.4% | 69,450 | 0.0% | 0.09% | -12.1% |
| Q3 2017 | $2,778,000 | -29.7% | 69,450 | -24.2% | 0.11% | -32.3% |
| Q2 2017 | $3,949,000 | +41.8% | 91,625 | +3.0% | 0.16% | +49.1% |
| Q1 2017 | $2,784,000 | +31.3% | 88,950 | +5.9% | 0.11% | +23.3% |
| Q4 2016 | $2,121,000 | – | 84,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |